NOVAVAX INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
NOVAVAX INC (NVAX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $27.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-06
- NOVAVAX INC share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-06-30 was $3.00M, a 50.00% increase year-over-year.
- NOVAVAX INC share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $24.00M, a 50.00% increase year-over-year.
- NOVAVAX INC share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $1.00M, a 66.67% decline year-over-year.
- NOVAVAX INC share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $1.00M, a 90.00% decline year-over-year.
- NOVAVAX INC share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $20.00M, a 53.85% increase from fiscal 2024.
- NOVAVAX INC share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $13.00M, a 160.00% increase from fiscal 2023.
- NOVAVAX INC share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $5.00M, a 76.19% decline from fiscal 2022.
- NOVAVAX INC share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $21.00M, a 95.37% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $27.00M 10-Q · filed 2026-08-06 | $28.00M derived: sum of 3 quarters · filed 2026-08-06 | $29.00M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $24.00M 10-Q · filed 2026-05-06 | $25.00M derived: sum of 2 quarters · filed 2026-05-06 | $26.00M derived: sum of 3 quarters · filed 2026-05-06 | $28.00M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.00M derived: sum of 2 quarters · filed 2026-02-26 | $4.00M derived: sum of 3 quarters · filed 2026-08-06 | $20.00M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.00M derived: sum of 2 quarters · filed 2026-08-06 | $19.00M 10-Q · filed 2025-11-06 | $22.00M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $18.00M 10-Q · filed 2026-08-06 | $21.00M derived: sum of 3 quarters · filed 2026-08-06 | $31.00M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $16.00M 10-Q · filed 2026-05-06 | $16.20M 10-Q · filed 2025-05-08 | $19.00M derived: sum of 2 quarters · filed 2026-05-06 | $29.00M derived: sum of 3 quarters · filed 2026-05-06 | $37.00M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $13.00M derived: sum of 2 quarters · filed 2026-02-26 | $21.00M derived: sum of 3 quarters · filed 2026-02-26 | $13.00M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $10.00M 10-Q · filed 2024-11-12 | $18.00M derived: sum of 2 quarters · filed 2024-11-12 | $10.00M 10-Q · filed 2025-11-06 | $24.50M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $8.00M 10-Q · filed 2024-08-08 | $8.00M 10-Q · filed 2025-08-06 | $14.50M derived: sum of 3 quarters · filed 2026-02-26 | $17.50M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | $4.50M 10-Q · filed 2025-05-08 | $6.50M derived: sum of 2 quarters · filed 2026-02-26 | $9.50M derived: sum of 3 quarters · filed 2026-02-26 | $11.50M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.00M derived: sum of 2 quarters · filed 2026-02-26 | $7.00M derived: sum of 3 quarters · filed 2026-02-26 | $5.00M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $3.00M 10-Q · filed 2024-11-12 | $5.00M derived: sum of 2 quarters · filed 2024-11-12 | $3.00M 10-Q · filed 2024-11-12 | $8.50M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | $2.00M 10-Q · filed 2024-08-08 | $2.00M 10-Q · filed 2024-08-08 | $5.50M derived: sum of 3 quarters · filed 2025-02-27 | $16.50M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | $1.50M 10-Q · filed 2024-05-10 | $3.50M derived: sum of 2 quarters · filed 2025-02-27 | $14.50M derived: sum of 3 quarters · filed 2025-02-27 | $16.90M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $13.00M derived: sum of 2 quarters · filed 2025-02-27 | $15.40M derived: sum of 3 quarters · filed 2025-02-27 | $21.00M 10-K · filed 2025-02-27 | $21.40M 10-K · filed 2023-02-28 | ||
| 2022-09-30 | $11.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $13.40M derived: sum of 2 quarters · filed 2023-11-09 | $19.00M 10-Q · filed 2023-11-09 | $92.00M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | $2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $8.00M 10-Q · filed 2023-08-08 | $81.00M derived: sum of 3 quarters · filed 2024-02-28 | $347.00M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-03-31 | $5.60M 10-Q · filed 2023-05-09 | $78.60M derived: sum of 2 quarters · filed 2024-02-28 | $344.60M derived: sum of 3 quarters · filed 2024-02-28 | $378.10M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | $73.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $339.00M derived: sum of 2 quarters · filed 2024-02-28 | $372.50M derived: sum of 3 quarters · filed 2024-02-28 | $454.00M 10-K · filed 2024-02-28 | $453.80M 10-K · filed 2022-03-01 | ||
| 2021-09-30 | $266.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $299.50M derived: sum of 2 quarters · filed 2022-11-09 | $381.00M 10-Q · filed 2022-11-09 | $404.30M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | $33.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $115.00M 10-Q · filed 2022-08-09 | $138.30M derived: sum of 3 quarters · filed 2023-02-28 | $294.30M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | $81.50M 10-Q · filed 2022-05-10 | $104.80M derived: sum of 2 quarters · filed 2023-02-28 | $260.80M derived: sum of 3 quarters · filed 2023-02-28 | $268.60M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $23.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $179.30M derived: sum of 2 quarters · filed 2023-02-28 | $187.10M derived: sum of 3 quarters · filed 2023-02-28 | $187.30M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $156.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $163.80M derived: sum of 2 quarters · filed 2021-11-05 | $164.00M 10-Q · filed 2021-11-05 | $164.30M 10-Q · filed 2020-11-10 | $164.40M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $7.80M 10-Q · filed 2020-08-10 | $8.00M 10-Q · filed 2021-08-05 | $8.40M derived: sum of 3 quarters · filed 2022-03-01 | $8.40M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | $200.00K 10-Q · filed 2021-05-10 | $600.00K derived: sum of 2 quarters · filed 2022-03-01 | $600.00K derived: sum of 3 quarters · filed 2022-03-01 | $700.00K derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $400.00K derived: sum of 2 quarters · filed 2022-03-01 | $500.00K derived: sum of 3 quarters · filed 2022-03-01 | $500.00K 10-K · filed 2022-03-01 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $100.00K derived: sum of 2 quarters · filed 2020-11-10 | $100.00K 10-Q · filed 2020-11-10 | $300.00K derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | $100.00K 10-Q · filed 2020-08-10 | $100.00K 10-Q · filed 2019-08-07 | $300.00K derived: sum of 3 quarters · filed 2021-03-01 | $300.00K derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | $100.00K 10-Q · filed 2020-05-11 | $200.00K derived: sum of 2 quarters · filed 2021-03-01 | $200.00K derived: sum of 3 quarters · filed 2021-03-01 | $200.00K derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $100.00K derived: sum of 2 quarters · filed 2021-03-01 | $100.00K derived: sum of 3 quarters · filed 2021-03-01 | $400.00K 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $300.00K 10-Q · filed 2019-11-07 | $300.00K derived: sum of 4 quarters · filed 2020-03-11 | |||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $300.00K 10-Q · filed 2019-08-07 | $300.00K derived: sum of 3 quarters · filed 2020-03-11 | $300.00K derived: sum of 4 quarters · filed 2020-03-11 | |||
| 2018-03-31 | $300.00K 10-Q · filed 2019-05-02 | $300.00K derived: sum of 2 quarters · filed 2020-03-11 | $300.00K derived: sum of 3 quarters · filed 2020-03-11 | $300.00K derived: sum of 4 quarters · filed 2020-03-11 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $0.00 derived: sum of 2 quarters · filed 2020-03-11 | $0.00 derived: sum of 3 quarters · filed 2020-03-11 | $100.00K 10-K · filed 2020-03-11 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $100.00K 10-Q · filed 2018-11-07 | $100.00K derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $100.00K 10-Q · filed 2018-08-08 | $100.00K derived: sum of 3 quarters · filed 2019-03-18 | $400.00K derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2017-03-31 | $100.00K 10-Q · filed 2018-05-09 | $100.00K derived: sum of 2 quarters · filed 2019-03-18 | $400.00K derived: sum of 3 quarters · filed 2019-03-18 | $700.00K derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $300.00K derived: sum of 2 quarters · filed 2019-03-18 | $600.00K derived: sum of 3 quarters · filed 2019-03-18 | $2.40M 10-K · filed 2019-03-18 | |||
| 2016-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $600.00K derived: sum of 2 quarters · filed 2017-11-07 | $2.40M 10-Q · filed 2017-11-07 | $3.10M derived: sum of 4 quarters · filed 2018-03-14 | |||
| 2016-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $2.10M 10-Q · filed 2016-08-09 | $2.80M derived: sum of 3 quarters · filed 2018-03-14 | $5.80M derived: sum of 4 quarters · filed 2018-03-14 | |||
| 2016-03-31 | $1.80M 10-Q · filed 2017-05-08 | $2.50M derived: sum of 2 quarters · filed 2018-03-14 | $5.50M derived: sum of 3 quarters · filed 2018-03-14 | $7.70M derived: sum of 4 quarters · filed 2018-03-14 | |||
| 2015-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $3.70M derived: sum of 2 quarters · filed 2018-03-14 | $5.90M derived: sum of 3 quarters · filed 2018-03-14 | $9.70M 10-K · filed 2018-03-14 | |||
| 2015-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $5.20M derived: sum of 2 quarters · filed 2016-11-09 | $9.00M 10-Q · filed 2016-11-09 | $10.60M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $6.00M 10-Q · filed 2016-08-09 | $7.60M derived: sum of 3 quarters · filed 2017-02-27 | $7.70M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-03-31 | $3.80M 10-Q · filed 2016-05-05 | $5.40M derived: sum of 2 quarters · filed 2017-02-27 | $5.50M derived: sum of 3 quarters · filed 2017-02-27 | $5.80M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2014-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $1.70M derived: sum of 2 quarters · filed 2017-02-27 | $2.00M derived: sum of 3 quarters · filed 2017-02-27 | $3.40M 10-K · filed 2017-02-27 | |||
| 2014-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $400.00K derived: sum of 2 quarters · filed 2015-11-09 | $1.80M 10-Q · filed 2015-11-09 | $2.10M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $1.70M 10-Q · filed 2015-08-10 | $2.00M derived: sum of 3 quarters · filed 2016-02-29 | $2.20M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $1.40M 10-Q · filed 2015-05-07 | $1.70M derived: sum of 2 quarters · filed 2016-02-29 | $1.90M derived: sum of 3 quarters · filed 2016-02-29 | $1.90M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $500.00K derived: sum of 2 quarters · filed 2016-02-29 | $500.00K derived: sum of 3 quarters · filed 2016-02-29 | $600.00K 10-K · filed 2016-02-29 | |||
| 2013-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $200.00K derived: sum of 2 quarters · filed 2014-11-06 | $300.00K 10-Q · filed 2014-11-06 | $300.00K derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $100.00K 10-Q · filed 2014-08-07 | $100.00K derived: sum of 3 quarters · filed 2015-02-27 | $100.00K derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-03-31 | $100.00K 10-Q · filed 2014-05-08 | $100.00K derived: sum of 2 quarters · filed 2015-02-27 | $100.00K derived: sum of 3 quarters · filed 2015-02-27 | $100.00K derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $0.00 derived: sum of 2 quarters · filed 2015-02-27 | $0.00 derived: sum of 3 quarters · filed 2015-02-27 | $100.00K 10-K · filed 2015-02-27 | |||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $100.00K 10-Q · filed 2013-11-12 | $200.00K derived: sum of 4 quarters · filed 2014-03-12 | |||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $100.00K 10-Q · filed 2013-08-08 | $200.00K derived: sum of 3 quarters · filed 2014-03-12 | ||||
| 2012-03-31 | $100.00K 10-Q · filed 2013-05-09 | $200.00K derived: sum of 2 quarters · filed 2014-03-12 | |||||
| 2011-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $300.00K 10-K · filed 2014-03-12 | |||||
| 2011-09-30 | $200.00K 10-Q · filed 2012-11-09 | ||||||
| 2010-12-31 | $300.00K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |